1
|
Afsar S, Yigit A, Ozcaglayan R, Usta CS, Bulbul CB, Turan G. Fetuin-A expression in human umbilical vein endothelial cells and amnion cells of patients with gestational diabetes mellitus. Saudi Med J 2022; 43:694-699. [PMID: 35831000 PMCID: PMC9749698 DOI: 10.15537/smj.2022.43.7.20220283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 06/15/2022] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES To elucidate the link between fetuin-A expression in human umbilical vein endothelial cells (HUVECs) and amnion cells (ACs) and clinicopathological changes in patients with gestational diabetes mellitus (GDM) and newborns. METHODS This retrospective cohort study included 82 pregnant patients (40 with GDM and 42 controls) between January 2019 and January 2022. The patients underwent a one-hour, 50 gram glucose challenge test (GCT) during the 24-28th weeks of pregnancy. Patients with positive GCTs immediately underwent a 3-hour, 100 gram oral glucose tolerance test. The expression level of fetuin-A in UVECs and ACs was evaluated by immunohistochemistry (IHC) and scored based on IHC staining in randomly selected slides. The IHC staining intensity was evaluated by the number of dots, which reflects the expression level of fetuin-A in both HUVECs and ACs. RESULTS The GDM group displayed significantly higher fetuin-A expression in both HUVECs (p<0.0001) and ACs (p=0.0001) when compared with the control group. Fetuin-A expression in HUVECs was correlated with fetal macrosomia, neonatal hypoglycemia, and placental weight. However, there was no correlation with fetuin-A expression in ACs. CONCLUSION There is a correlation between fetal macrosomia, neonatal hypoglycemia, placental weight, and fetuin-A expression of HUVECs in patients with GDM.
Collapse
Affiliation(s)
- Selim Afsar
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
- Address correspondence and reprint request to: Dr. Selim Afsar, Department of Obstetrics and Gynecology, Faculty of Medicine, Balıkesir University, Balikesir, Turkey. E-mail: ORCID ID: https://orcid.org/0000-0002-2757-1765
| | - Ayse Yigit
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
| | - Ruhsen Ozcaglayan
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
| | - Ceyda S. Usta
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
| | - Cagla B. Bulbul
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
| | - Gulay Turan
- From the Department of Obstetrics and Gynecology (Afsar, Usta, Bulbul); from the Department of Internal Medicine (Ozcaglayan); from the Department of Pathology (Turan), School of Medicine, Balikesir University, Balikesir, and from the Department of Obstetrics and Gynecology (Yigit), Adana Yuregir Devlet Hastanesi, Adana, Turkey.
| |
Collapse
|
2
|
Usta CS, Atik TK, Ozcaglayan R, Bulbul CB, Camili FE, Adali E. Does the fibrinogen/albumin ratio predict the prognosis of pregnancies with abortus imminens? Saudi Med J 2021; 42:255-263. [PMID: 33632903 PMCID: PMC7989262 DOI: 10.15537/smj.2021.42.3.20200695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Accepted: 01/20/2021] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES To investigate the fibrinogen/albumin ratio (FAR) of pregnant women with abortus imminens (AI) and its prognostic value for predicting spontaneous abortion. METHODS A total 102 early pregnancies, 52 had been diagnosed with AI and 50 ages and body mass index matched healthy control pregnant women were included in this prospective observational study conducted in the Research and Training Hospital, Balikesir University, Balikesir, Turkey between September 2019 and August 2020. Fibrinogen/albumin values were compared between AI and control group. RESULTS The rate of spontaneous abortion in AI pregnancies was 26.9% in our study population. Fibrinogen/albumin ratio levels were higher in AI pregnancies than in controls (p=0.0088). The regression analysis have shown that the increased FAR value (odds ratio [OR]: 7.3116 [95% CI: 1.3119 to 40.7507]; p=0.0232) was an independent marker for spontaneous abortion prediction in AI pregnancies. CONCLUSION Pregnancies with AI have increased levels of FAR compared to healthy pregnancies. Fibrinogen/albumin ratio is an independent marker for predicting spontaneous abortion.
Collapse
Affiliation(s)
- Ceyda S. Usta
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
- Address correspondence and reprint request to: Dr. Ceyda S. Usta, Department of Obstetrics and Gynecology, School of Medicine, Balikesir University, Balikesir, Turkey. E-mail: ORCID ID: https://orcid.org/0000-0002-3223-7729
| | - Tugba K. Atik
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
| | - Ruhsen Ozcaglayan
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
| | - Cagla B. Bulbul
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
| | - Figen E. Camili
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
| | - Ertan Adali
- From the Department of Obstetrics and Gynecology (Usta, Bulbul, Camili), from the Department of Clinical Microbiology (Atik), and from the Department of Internal Medicine (Ozcaglayan), School of Medicine, Balikesir University, Balikesir, Turkey.
| |
Collapse
|